Epirubicin plus tamoxifen versus tamoxifen alone in post-menopausal node positive primary breast cancer Not provided at time of registration

• Country None
• organs None
• Specialty None

An adjuvant randomised study comparing standard dose FE[50]C with a higher dose FE[75]C and evaluating the additional benefit of sequential hormone therapy in node positive pre-menopausal primary breast cancer Not provided at time of registration

• Country None
• organs None
• Specialty None

Randomised phase II study of sequentially high dose Methotrexate and Fluorouracil combined with Epirubicin (FEMTX) versus FEMTX plus Cisplatin (FEMTX-P) in advanced gastric cancer Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None

A Prospective Randomised Comparison of CMF versus Sequential Epirubicin Followed by CMF as Adjuvant Chemotherapy for Women with Early Breast Cancer http://cancerhelp.cancerresearchuk.org/trials/national-breast-cancer-study-of-epirubicin-as-adjuvant-therapy

• Country United Kingdom
• organs None
• Specialty None

A randomised double-blind trial in post-menopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years, comparing subsequent adjuvant exemestane treatment with further tamoxifen Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None

Adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) versus 5-Fluorouracil, epirubicin and cyclosphosphamide (FEC) in node negative poor-risk primary breast cancer Not provided at time of registration

• Country None
• organs None
• Specialty None

Phase III Randomised Study of High Dose Methotrexate and 5-Fluouracil Combined with Epirubicin (FEMTX) versus No Treatment in Stage II-III Resected Gastric Cancer Not provided at time of registration

• Country United Kingdom
• organs None
• Specialty None